Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), oktober 17, 2023 Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Carcinoma, Non-Small-Cell Lung;Mesothelioma, Date of authorisation: 18/01/2016, Revision: 14, Status: Authorised Lees verder » Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief. Delen Link ophalen Facebook X Pinterest E-mail Andere apps Delen Link ophalen Facebook X Pinterest E-mail Andere apps